Dr. O’Malley is an internationally recognized leader in the field of addiction science and Deputy Chair of Clinical Research in the Department of Psychiatry at Yale School of Medicine. Dr. O’Malley has extensive experience in conducting studies of pharmacological and behavioral interventions for alcohol and tobacco. As Principal Investigator, Dr. O’Malley leads the Yale site for the HLAB study.
Dr. Muvvala is the medical director of the Substance Abuse Treatment Unit. Dr. Muvvala oversees the medical aspects of the protocol, including final review of eligibility related to medical inclusion/exclusion criteria and ongoing review of participant safety.
Denise Romano, APRN, Family Nurse Practitioner, Study Nurse
Ms. Romano is responsible for medical screening of potential participants for admission into the HLAB Study. She conducts physical exams to determine eligibility related to medical inclusion/exclusion criteria. Ms. Romano has extensive experience in clinical trials and was responsible for similar tasks at Yale’s site for the COMBINE and HLAB-01 Study.
Thomas Liss, B.S, Project Coordinator
Thomas is responsible for coordinating various aspects of the study including recruitment, screening, scheduling, and study appointments. Thomas has been working at Yale for over 15 years and has extensive experience coordinating clinical trials.
Other Study Personnel and Collaborators:
- Suchitra Krishnan-Sarin, PhD
- Will Rutland, M.D.
- Elaine Lavelle, M.S.
- Angela Haeny, PhD
- Heather LaVallee, MA, LMFTA
- Ruth-Ann Lowers